Crohn Disease

Featured Article
The ACG’s treatment guidelines for Crohn disease offer significant lessons for physicians. David A. Schwartz, MD, provided an overview at the Advances in Inflammatory Bowel Disease virtual regional meeting on September 12.
In her session, Millie Long, MD, reviewed the role of anticytokine therapy for treating Crohn disease and how new approaches to diagnosing, monitoring, and treating Crohn disease have helped advance the care of patients with inflammatory bowel disease.
A previously healthy 9-year-old girl presented to the emergency department for evaluation of fever, unilateral ankle pain and swelling, and an inability to bear weight.
Anti-tumor necrosis factor agents and/or thiopurines can prevent recurrence of Crohn disease in surgically treated patients, said Miguel Regueiro, MD, from the Cleveland Clinic, at the 2019 AIBD Meeting.
In a new study presented at the 2019 AIBD Meeting, researchers assessed the prevalence of anastomotic ring inflammation (ARI) in patients with Crohn disease who undergo ileal resection and ileocolonic anastomosis, as well as risk factors associated with ARI.
A previously healthy 7-year-old boy presented after 3 weeks of recurrent fevers, left lower-extremity pain, and mild diarrhea.
Russell Cohen, MD, from the University of Chicago Pritzker School of Medicine, highlights recent and emerging therapies for Crohn disease during one of his sessions at the AIBD Regionals Meeting in Boston.
Researchers analyzed results of the REACT clinical trial to determine whether age affects the safety and efficacy of early combined immunosuppressive treatment in Crohn disease.
Because diet may play a role in the progression of Crohn disease, researchers of the Food and Crohn’s Disease Exacerbation Study evaluated the effect of red or processed meat on symptomatic relapse.
Researchers analyzed whether health care providers are meeting the clinical needs of patients with Crohn disease during pregnancy.
Researchers performed small RNA sequencing of colon tissue from more than 100 individuals to better understand cellular mechanisms that create heterogeneity in CD.